VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,000 | +33.3% | 365 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $6,000 | -25.0% | 365 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $8,000 | 0.0% | 365 | -35.6% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | 0.0% | 567 | +30.3% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | +700.0% | 435 | +911.6% | 0.00% | +300.0% |
| Q3 2016 | $1,000 | – | 43 | +115.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 20 | -58.3% | 0.00% | -100.0% |
| Q1 2016 | $1,000 | -83.3% | 48 | -14.3% | 0.00% | -75.0% |
| Q4 2015 | $6,000 | -33.3% | 56 | +5.7% | 0.00% | -33.3% |
| Q3 2015 | $9,000 | +12.5% | 53 | +43.2% | 0.01% | +20.0% |
| Q2 2015 | $8,000 | +14.3% | 37 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $7,000 | +133.3% | 37 | +76.2% | 0.00% | +100.0% |
| Q4 2014 | $3,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |